CoreCap Advisors’s Sotera Health SHC Stock Holding History

CoreCap Advisors’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20	Closed	-$274	–	3283
2024 Q4	$274	Buy	+20	New	+$290	﹤0.01%	2654

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CoreCap Advisors's SHC Position: Q1 2025 in Review

CoreCap Advisors sold out of Sotera Health (SHC) in Q1 2025, closing a stake of 20 shares — an estimated $274 sold.

CoreCap Advisors first reported a position in SHC in Q4 2024 and held it in 1 quarter. The position peaked at $274 in Q4 2024. 205 funds tracked by Wall St. Rank hold SHC as of Q1 2025.

CoreCap Advisors reported no remaining Sotera Health position as of Q1 2025 after selling out during the quarter.
CoreCap Advisors sold 20 Sotera Health shares in Q1 2025, an estimated $274.
CoreCap Advisors first reported a position in Sotera Health in Q4 2024 and held it in 1 quarter.
CoreCap Advisors's Sotera Health position peaked at $274 in Q4 2024.
205 funds tracked by Wall St. Rank held Sotera Health as of Q1 2025.

Based on CoreCap Advisors's 13F filing for Q1 2025, filed 9 May 2025.